Methemoglobinemia secondary to rasburicase in cancer: Non drug-related oxidative stress

Abstract

Get full access to this article

View all access options for this article.

References

Edwards

Egelund

. Methemoglobinemia induced by rasburicase in a pediatric patient: a case report and literature review. J Oncol Pharm Pract 2012; 18: 425–431.

Soares

Feres

Salluh

. Systemic inflammatory response syndrome and multiple organ dysfunction in patients with acute tumor lysis syndrome. Clinics (Sao Paulo) 2009; 64: 479–481.

Oberley

. Antioxidant enzyme levels in cancer. Histol Histopathol 1997; 12: 525–535.

Góth

Bigler

. Catalase deficiency may complicate urate oxidase (rasburicase) therapy. Free Radic Res 2007; 41: 953–955.

Ames

Cathcart

Schwiers

. Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981; 78: 6858–6862.

Folch

Gelpí

Roselló-Catafau

. Free radicals generated by xanthine oxidase mediate pancreatitis-associated organ failure. Dig Dis Sci 1998; 43: 2405–2405.

Bucklin

Groth

. Mortality following rasburicase-induced methemoglobinemia. Ann Pharmacother 2013; 47: 1353–1358.

Harris

Orsini

Wolk

. Vitamin C and survival among women with breast cancer: a meta-analysis. Eur J Cancer 2014; 50: 1223–1231.